Hubei Jumpcan Pharmaceutical Co., Ltd.

XSSC:600566 Stock Report

Market Cap: CN¥24.1b

Hubei Jumpcan Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Fei Cao

Chief executive officer

CN¥3.0m

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownershipn/a
Management average tenure6yrs
Board average tenure6.6yrs

Recent management updates

Recent updates


CEO

Fei Cao (41 yo)

5.3yrs

Tenure

CN¥3,045,000

Compensation

Mr. Fei Cao serves as General Manager of Jiangsu Jumpcan Holding Group Co., Ltd. Mr. Cao serves as Chairman of Shaanxi Dongke Pharmaceutical Co., Ltd. He serves as Vice Chairman of Hubei Jumpcan Pharmaceut...


Leadership Team

NamePositionTenureCompensationOwnership
Fei Cao
Vice Chairman & GM5.3yrsCN¥3.05mno data
Qu Rong Huang
Vice Chairman11.1yrsCN¥2.00m0.042%
CN¥ 10.0m
Hong Quan Yan
Deputy GM & Financial Director2.6yrsCN¥1.70m0.030%
CN¥ 7.3m
Wen Zheng Shi
Director of Human Resources11.1yrsCN¥1.15m0.018%
CN¥ 4.3m
Wei Cao
Deputy GM6.6yrsCN¥2.66m0.026%
CN¥ 6.3m
Qi Hua Zhou
Deputy General Manager11.1yrsCN¥1.58m0.027%
CN¥ 6.4m
Qian Zhao
Deputy General Manager2.8yrsCN¥1.50mno data

6.0yrs

Average Tenure

44yo

Average Age

Experienced Management: 600566's management team is seasoned and experienced (6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fei Cao
Vice Chairman & GM11.1yrsCN¥3.05mno data
Qu Rong Huang
Vice Chairman11.1yrsCN¥2.00m0.042%
CN¥ 10.0m
Wei Cao
Deputy GM6.6yrsCN¥2.66m0.026%
CN¥ 6.3m
Long Xiang Cao
Chairman11.1yrsCN¥4.50m5.08%
CN¥ 1.2b
Hong Yao
Independent Director5.1yrsCN¥120.00kno data
Chaojun Lu
Independent Director5.1yrsCN¥120.00kno data
Xinchun Zhou
Chairman of the Supervisory Board5.9yrsno datano data
Shan Shi
Employee Supervisor7yrsno datano data
Yuhai Yang
Independent Director2.5yrsCN¥120.00kno data

6.6yrs

Average Tenure

53yo

Average Age

Experienced Board: 600566's board of directors are considered experienced (6.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/18 11:46
End of Day Share Price 2025/04/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hubei Jumpcan Pharmaceutical Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Lan LanFounder Securities Co., Ltd.
Wen DaiHuatai Research